Jonathan Rigby
Vermogen: 35 630 $ op 31-10-2026
Vermogen: 35 630 $ op 31-10-2026
Jonathan M.
N.
Rigby was the founder of Zogenix, Inc., established in 2006, where the title held was Vice President-Business Development from 2006 to 2010.
Current jobs include President, Chief Executive Officer & Director at Sernova Biotherapeutics, Inc. starting in 2025; Chairman of the Association of Needle-Free Injection Manufacturers since 2010; Chairman & Chief Business Officer at BioPlus Acquisition Corp.
since 2021; Director at Thermalin, Inc.; Director at Aurimi Therapeutics, Inc. since 2021; Director at ReAlta Life Sciences, Inc.; Director at Exciting Instruments Ltd.; and Independent Director at Oncolytics Biotech, Inc. since 2022.
Former jobs include President, Chief Executive Officer & Director at SteadyMed Ltd. from 2011 to 2020; President, Chief Executive Officer & Director at SteadyMed Therapeutics, Inc. from 2011 to 2019; President, Group CEO & Director at Revolo Biotherapeutics Ltd. from 2020 to 2024; Chairman at CollPlant Biotechnologies Ltd. in 2019; Independent Non-Executive Director at Xeris Pharmaceuticals, Inc. from 2016 to 2019; Principal at Merck & Co., Inc.; Vice President-Business Development at Aradigm Corp.
from 2002 to 2006; and Head-Business Development & Sales at Respironics Ltd. from 1995 to 2002.
Education includes undergraduate studies at The University of Sheffield and an MBA from the University of Portsmouth.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-09-2026 | 42.728 ( 0,03% ) | 18 159 $ | 31-10-2026 | |
| 14-04-2026 | 229.877 ( 0,06% ) | 17 471 $ | 31-10-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SERNOVA BIOTHERAPEUTICS INC | Algemeen Directeur | 12-08-2024 |
| BIOPLUS ACQUISITION CORP. | Voorzitter | 01-07-2021 |
| ONCOLYTICS BIOTECH INC. | Directeur/Bestuurslid | 30-08-2022 |
Association of Needle-Free Injection Manufacturers | Voorzitter | 07-09-2010 |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno-therapeutic drugs for autoimmune diseases | Directeur/Bestuurslid | 27-01-2021 |
Thermalin, Inc.
Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Develops insulin treatments for patients with diabetes | Directeur/Bestuurslid | - |
ReAlta Life Sciences, Inc.
ReAlta Life Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel class of drugs with dual-targeting therapeutic capabilities | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops immunologic and inflammatory medications | Algemeen Directeur | 22-02-2024 |
| STEADYMED LTD | Algemeen Directeur | 01-01-2020 |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 18 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Aradigm Corp.
Aradigm Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for the treatment and prevention of respiratory diseases | Health Technology |
Oncolytics Biotech, Inc.
Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
Sernova Biotherapeutics, Inc.
Sernova Biotherapeutics, Inc. BiotechnologyHealth Technology Develops life science products | Health Technology |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
Zogenix, Inc.
Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medicines | Health Technology |
Respironics Ltd.
Respironics Ltd. Financial ConglomeratesFinance Develops and manufactures medical and healthcare products | Finance |
The University of Sheffield
The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Portsmouth
University of Portsmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association of Needle-Free Injection Manufacturers | |
SteadyMed Therapeutics, Inc.
SteadyMed Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops drug delivery therapeutics devices | Health Services |
Thermalin, Inc.
Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Develops insulin treatments for patients with diabetes | Health Technology |
CollPlant Biotechnologies Ltd.
CollPlant Biotechnologies Ltd. Medical SpecialtiesHealth Technology Develops and commercializes medical devices | Health Technology |
SteadyMed Ltd.
SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, and manufacture of pharmaceutical products | Health Technology |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno-therapeutic drugs for autoimmune diseases | Health Technology |
Revolo Biotherapeutics Ltd.
Revolo Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops immunologic and inflammatory medications | Health Technology |
ReAlta Life Sciences, Inc.
ReAlta Life Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops novel class of drugs with dual-targeting therapeutic capabilities | Health Technology |
BioPlus Acquisition Corp.
BioPlus Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Kies jouw editie
Alle financiële informatie op nationaal niveau